Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lemur tyrosine kinase 3 (LMTK3) is a protein kinase primarily functioning as a serine/threonine kinase. It is involved in gene regulation, protein trafficking, and oncogenesis. Overexpression is linked to several cancers, including breast, glioblastoma, and lung cancers. It also plays a role in central nervous system function, with knockout mice showing hyperactivity and cognitive impairments. The small molecule inhibitor C28 demonstrates anti-cancer activity by disrupting LMTK3's interaction with HSP90.
Disrupts interaction with HSP90, leading to degradation of LMTK3; inhibits tumor growth and induces apoptosis; inhibits PKC; Direct phosphorylation of ERα
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lemur Tyrosine Kinase 3 (LMTK3).